BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 15167937)

  • 1. Prognostic significance of HER2/neu, p53, and vascular endothelial growth factor expression in early stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung.
    Saad RS; Liu Y; Han H; Landreneau RJ; Silverman JF
    Mod Pathol; 2004 Oct; 17(10):1235-42. PubMed ID: 15167937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single institution-based retrospective study of surgically treated bronchioloalveolar adenocarcinoma of the lung: clinicopathologic analysis, molecular features, and possible pitfalls in routine practice.
    Casali C; Rossi G; Marchioni A; Sartori G; Maselli F; Longo L; Tallarico E; Morandi U
    J Thorac Oncol; 2010 Jun; 5(6):830-6. PubMed ID: 20521350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of immunohistochemical expressions of p53, HER-2/neu, and bcl-2 in stage I non-small-cell lung cancer.
    Han H; Landreneau RJ; Santucci TS; Tung MY; Macherey RS; Shackney SE; Sturgis CD; Raab SS; Silverman JF
    Hum Pathol; 2002 Jan; 33(1):105-10. PubMed ID: 11823980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of thyroid transcription factor-1 expression in both early-stage conventional adenocarcinoma and bronchioloalveolar carcinoma of the lung.
    Saad RS; Liu YL; Han H; Landreneau RJ; Silverman JF
    Hum Pathol; 2004 Jan; 35(1):3-7. PubMed ID: 14745718
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the characteristics in recurrence and metastasis between bronchioloalveolar carcinoma and other lung adenocarcinomas].
    Zhong XJ; Li DT; Li XL; Mu DB; Zhang XG; Luo JY
    Ai Zheng; 2007 Jul; 26(7):785-9. PubMed ID: 17626761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synchronous overexpression of epidermal growth factor receptor and HER2-neu protein is a predictor of poor outcome in patients with stage I non-small cell lung cancer.
    Onn A; Correa AM; Gilcrease M; Isobe T; Massarelli E; Bucana CD; O'Reilly MS; Hong WK; Fidler IJ; Putnam JB; Herbst RS
    Clin Cancer Res; 2004 Jan; 10(1 Pt 1):136-43. PubMed ID: 14734462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor histology and stage but not p53, Her2-neu or cathepsin-D expression are independent prognostic factors in breast cancer patients.
    Korkolis DP; Tsoli E; Fouskakis D; Yiotis J; Koullias GJ; Giannopoulos D; Papalambros E; Nikiteas NI; Spiliopoulou CA; Patsouris E; Asimacopoulos P; Gorgoulis VG
    Anticancer Res; 2004; 24(3b):2061-8. PubMed ID: 15274401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological and molecular evidence indicating the independence of bronchioloalveolar components from other subtypes of human peripheral lung adenocarcinoma.
    Koga T; Hashimoto S; Sugio K; Yoshino I; Mojtahedzadeh S; Matsuo Y; Yonemitsu Y; Sugimachi K; Sueishi K
    Clin Cancer Res; 2001 Jun; 7(6):1730-8. PubMed ID: 11410513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of basal/myoepithelial markers in benign and malignant bronchioloalveolar proliferations of the lung.
    Saad RS; Liu YL; Silverman JF
    Appl Immunohistochem Mol Morphol; 2010 May; 18(3):219-25. PubMed ID: 20065853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchioloalveolar carcinoma of mixed mucinous and nonmucinous type: immunohistochemical studies and mutation analysis of the p53 gene.
    Sato K; Ueda Y; Shikata H; Katsuda S
    Pathol Res Pract; 2006; 202(10):751-6. PubMed ID: 16959434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of p53 and HER2/Neu in Kenyan Women With Primary Ovarian Carcinoma.
    Mutuiri AP; Nzioka A; Busarla SV; Sayed S; Moloo Z
    Int J Gynecol Pathol; 2016 Nov; 35(6):537-543. PubMed ID: 26825003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchioloalveolar carcinoma (lepidic growth) component is a more useful prognostic factor than lymph node metastasis.
    Anami Y; Iijima T; Suzuki K; Yokota J; Minami Y; Kobayashi H; Satomi K; Nakazato Y; Okada M; Noguchi M
    J Thorac Oncol; 2009 Aug; 4(8):951-8. PubMed ID: 19543119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Overexpression and prognostic value of p53 and HER2/neu proteins in benign ovarian tissue and in ovarian cancer].
    Coronado Martín PJ; Fasero Laiz M; García Santos J; Ramírez Mena M; Vidart Aragón JA
    Med Clin (Barc); 2007 Jan; 128(1):1-6. PubMed ID: 17266884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vascular endothelial growth factor and HER2/neu in stage II colon cancer and correlation with survival.
    Ochs AM; Wong L; Kakani V; Neerukonda S; Gorske J; Rao A; Riggs M; Ward H; Keville L
    Clin Colorectal Cancer; 2004 Nov; 4(4):262-7. PubMed ID: 15555209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuclear expression of p53, p21 and cyclin D1 is increased in bronchioloalveolar carcinoma.
    McDonald JW; Pilgram TK
    Histopathology; 1999 May; 34(5):439-46. PubMed ID: 10231419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bronchioloalveolar carcinomas. Cell types, patterns of growth, and prognostic correlates.
    Clayton F
    Cancer; 1986 Apr; 57(8):1555-64. PubMed ID: 3004694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maspin, VEGF and p53 expression in small biopsies of primary advanced lung cancer and relationship with clinicopathologic parameters.
    Bircan A; Bircan S; Kapucuoglu N; Songur N; Ozturk O; Akkaya A
    Pathol Oncol Res; 2010 Dec; 16(4):553-61. PubMed ID: 20349288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histopathologic features of the tumor budding in adenocarcinoma of the lung: tumor budding as an index to predict the potential aggressiveness.
    Yamaguchi Y; Ishii G; Kojima M; Yoh K; Otsuka H; Otaki Y; Aokage K; Yanagi S; Nagai K; Nishiwaki Y; Ochiai A
    J Thorac Oncol; 2010 Sep; 5(9):1361-8. PubMed ID: 20631633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of thyroid transcription factor-1 in identification of the prognosis of bronchioloalveolar carcinoma].
    Wang CL; Yue DS; Zhang ZF; Zhan ZL; Sun LN
    Zhonghua Yi Xue Za Zhi; 2007 Sep; 87(33):2350-4. PubMed ID: 18036300
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor mutation and p53 overexpression during the multistage progression of small adenocarcinoma of the lung.
    Yoo SB; Chung JH; Lee HJ; Lee CT; Jheon S; Sung SW
    J Thorac Oncol; 2010 Jul; 5(7):964-9. PubMed ID: 20512074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.